Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)
Genetics Institute (acquired by Wyeth Research, now Pfizer)
Isabelle founded the firm’s contracts specialists group, where she worked with clients, along with our talented collection of professionals, to develop efficient contracting processes and streamlined contract templates in the discovery, pre-clinical, and clinical phases of development.
While having stepped back from her management responsibilities, Isabelle continues to provide her 30+ years of specialized contracts management and negotiation experience to Faber clients in the healthcare and biopharmaceutical, industries. In the clinical trial setting, Isabelle helped clients effectively resolve challenging issues, such as CRO changes during ongoing, multi-national clinical studies, transfers of studies among sponsors, and engagement of multiple sites in investigator-initiated studies. Her vast experience spanned a wide range of companies within the industry, including startups, clinical stage companies, contract research organizations, consulting groups, and big pharma. This valuable knowledge provided her with a uniquely well-rounded perspective and understanding of day-to-day transactions common in the biopharmaceutical industry. Over her career, Isabelle was frequently invited to speak at industry conferences on topics ranging from clinical trial subject injury issues to international considerations when contracting for clinical trials abroad.
Millennium Pharmaceuticals (now Takeda Pharmaceutical Company, Limited)
Associate Director of Contracts Administration
Genetics Institute (now Pfizer)